Netramark arranges $3.5-million private placement

Executive Summary

• Netramark Holdings Inc. announced a non‑brokered private placement of up to 3.5 million units at $1.00 per unit, targeting gross proceeds of up to $3.5 million.
• Each unit consists of one common share and half of a common‑share purchase warrant (full warrant exercisable at $1.35 per share for two years).
• Net proceeds will be used for general working capital, further development and commercialization of the NetraAI platform, and to support existing and prospective biopharmaceutical collaborations.

Key Details

• Offering Size: Up to 3.5 million units (each unit = 1 common share + ½ warrant).
• Price per Unit: $1.00 → Maximum Gross Proceeds: $3.5 million.
• Warrant Terms: One whole warrant (two half‑warrants) gives the holder the right to purchase one additional common share at an exercise price of $1.35 per share, exercisable for two years from closing.
• Regulatory Basis: Offering relies on exemptions from prospectus requirements under Canadian securities laws; units and warrants subject to a statutory hold period of four months + one day.
• Use of Proceeds: General working capital and corporate purposes, specifically:
• Advancement and commercialization of the proprietary NetraAI platform.
• Support for ongoing and prospective biopharmaceutical engagements.

Notable Quotes

(No direct quotes were provided in the release.)